| Overview |
| bs-1520R-PE-Cy5 |
| CD7 Polyclonal Antibody, PE-Cy5 Conjugated |
| FCM |
| Human, Mouse |
| Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD7 |
| 181-240/240 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 924 |
| P09564 |
| Cell membrane |
| GP40; TP41; Tp40; LEU-9; T-cell antigen CD7; T-cell leukemia antigen; T-cell surface antigen Leu-9; CD7 |
| CD7 is a 40 kDa transmembrane, single-chain glycoprotein, which is a member of the immunoglobulin superfamily. CD7 is expressed by the majority of thymocytes and mature T cells, NK cells and pre-B cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development. The function of CD7 is not yet known although cross-linking of CD7 with induces a T cell transmembrane calcium flux and CD7 expression is induced by ionomycin. The CD7 molecule has been reported to be the receptor for the IgM-Fc portion (FcR mu) on the surface of T cells. |
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz